BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 8965601)

  • 21. Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials.
    Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Chayama K; Haruma K
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1566-70. PubMed ID: 17845684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prokinetics prescribing in paediatrics: evidence on cisapride, domperidone, and metoclopramide.
    Mt-Isa S; Tomlin S; Sutcliffe A; Underwood M; Williamson P; Croft NM; Ashby D
    J Pediatr Gastroenterol Nutr; 2015 Apr; 60(4):508-14. PubMed ID: 25825854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of non-ulcer dyspepsia].
    Cortese I; Maselli MA
    Clin Ter; 1990 Apr; 133(2):103-7. PubMed ID: 2140745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prokinetic agents.
    Reynolds JC; Putnam PE
    Gastroenterol Clin North Am; 1992 Sep; 21(3):567-96. PubMed ID: 1516959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders.
    Wiseman LR; Faulds D
    Drugs; 1994 Jan; 47(1):116-52. PubMed ID: 7510617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisapride and metoclopramide in the treatment of gastroesophageal reflux disease.
    Arabehety JT; Leitão OR; Fassler S; Olarte M; Serrano C
    Clin Ther; 1988; 10(4):421-8. PubMed ID: 3079010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cisapride efficacy in gastroesophageal reflux in children].
    Bottaro G; Rotolo N; Spina M; Azzaro F; Galletta C; Romano D; Castiglione N; Patanè R
    Pediatr Med Chir; 1993; 15(2):141-4. PubMed ID: 8321715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug therapy of gastrointestinal motility disorders].
    Jia B
    Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):151-2. PubMed ID: 7648932
    [No Abstract]   [Full Text] [Related]  

  • 29. [A retrospective study on the efficacy of the treatment of functional dyspepsia. An evaluation of 166 cases].
    Canepa G; Di Somma C; Arnulfo G; Frascio M; Berti Riboli E
    Minerva Med; 1991 Jun; 82(6):371-3. PubMed ID: 2067709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prokinetic agents in postgastrectomy patients.
    Patterson DJ
    Gastroenterol Clin North Am; 1994 Jun; 23(2):313-25. PubMed ID: 7915253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Domperidone versus cisapride in the treatment of infant regurgitation and increased acid gastro-oesophageal reflux: a pilot study.
    Hegar B; Alatas S; Advani N; Firmansyah A; Vandenplas Y
    Acta Paediatr; 2009 Apr; 98(4):750-5. PubMed ID: 19076984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.
    Van Outryve M; De Nutte N; Van Eeghem P; Gooris JP
    Scand J Gastroenterol Suppl; 1993; 195():47-52; discussion 52-3. PubMed ID: 8516658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of gastrointestinal motility beyond metoclopramide and domperidone : Pharmacological and clinical evidence for phytotherapy in functional gastrointestinal disorders.
    Madisch A; Vinson BR; Abdel-Aziz H; Kelber O; Nieber K; Kraft K; Storr M
    Wien Med Wochenschr; 2017 May; 167(7-8):160-168. PubMed ID: 28424994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Domperidone, a novel and safe gastrokinetic anti-nauseant for the treatment of dyspepsia and vomiting.
    Reyntjens AJ; Niemegeers CJ; Van Nueten JM; Laduron P; Heykants J; Schellekens KH; Marsboom R; Jageneau A; Broekaert A; Janssen PA
    Arzneimittelforschung; 1978; 28(7):1194-6. PubMed ID: 582708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and treatment of delayed gastric emptying.
    Ricci DA; McCallum RW
    Adv Intern Med; 1988; 33():357-84. PubMed ID: 3278511
    [No Abstract]   [Full Text] [Related]  

  • 36. Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders.
    McCallum RW; Prakash C; Campoli-Richards DM; Goa KL
    Drugs; 1988 Dec; 36(6):652-81. PubMed ID: 3065057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastroparesis and the current use of prokinetic drugs.
    Kendall BJ; McCallum RW
    Gastroenterologist; 1993 Jun; 1(2):107-14. PubMed ID: 8049884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prokinetic drugs].
    Hellström P
    Nord Med; 1992; 107(11):274-7. PubMed ID: 1448341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of prokinetic drugs for treatment of postoperative ileus in the horse.
    Dart AJ; Hodgson DR
    Aust Vet J; 1998 Jan; 76(1):25-31. PubMed ID: 9578763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study.
    Sabbatini F; Minieri M; Manzi G; Piai G; D'Angelo V; Mazzacca G
    Ital J Gastroenterol; 1991 Jan; 23(1):1-4. PubMed ID: 1747493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.